Provectus Biopharmaceuticals PVCT
OTC PVCT
$0.05 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Provectus Biopharmaceuticals (PVCT) Depreciation & Amortization (CF) (2010 - 2025)

Updated

Provectus Biopharmaceuticals (PVCT) posted Depreciation & Amortization (CF) of $465.00 for Q4 2025, down 0.2% from $466.00 a year earlier and down 0.2% from the prior quarter.

Analysis

Provectus Biopharmaceuticals (PVCT) Depreciation & Amortization (CF) (2010 - 2025) Analysis & Trends

For FY2025, Provectus Biopharmaceuticals' Depreciation & Amortization (CF) came in at $1,863, down 74.0% from FY2024.

  • Annual Depreciation & Amortization (CF) has declined for six consecutive years, with a five-year compound annual growth rate of -32.9% (FY2020 to FY2025).
  • In prior years, Provectus Biopharmaceuticals' Depreciation & Amortization (CF) was $7,157 in FY2024 (-19.8%), $8,921 in FY2023 (-18.1%), $10,895 in FY2022 (-15.3%) and $12,865 in FY2021 (-6.0%).
  • Quarterly Depreciation & Amortization (CF) has run from a low of $465.00 in Q2 2025 to a high of $3,218 in Q1 2022 over five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) has declined in each of the last five quarters, with an average decline of 39.6% over the last eight quarters.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q4 2023, with growth of 9.4%; the weakest was Q2 2025, with a decline of 79.1%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $466.00 (Q3 2025), $465.00 (Q2 2025) and $467.00 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 2.12 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 194.00 Mn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 1.93 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 98.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 1.62 Bn
10 Provectus Biopharmaceuticals 21.01 Mn 19.10 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 465.00
Sep 30, 2025 466.00
Jun 30, 2025 465.00
Mar 31, 2025 467.00
Dec 31, 2024 466.00
Sep 30, 2024 2,230.00
Jun 30, 2024 2,230.00
Mar 31, 2024 2,231.00
Dec 31, 2023 2,230.00
Sep 30, 2023 2,230.00
Jun 30, 2023 2,231.00
Mar 31, 2023 2,230.00
Dec 31, 2022 2,038.00
Sep 30, 2022 2,820.00
Jun 30, 2022 2,819.00
Mar 31, 2022 3,218.00
Dec 31, 2021 3,217.00
Sep 30, 2021 3,216.00
Jun 30, 2021 3,216.00
Mar 31, 2021 3,216.00
API Access

Provectus Biopharmaceuticals Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=PVCT&period=max&api_key=YOUR_API_KEY